Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | S21-S26 |
| Fachzeitschrift | European Journal of Health Economics |
| Jahrgang | 10 |
| Ausgabenummer | SUPPL. 1 |
| Frühes Online-Datum | 10 Dez. 2009 |
| Publikationsstatus | Veröffentlicht - Jan. 2010 |
Abstract
This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
ASJC Scopus Sachgebiete
- Volkswirtschaftslehre, Ökonometrie und Finanzen (insg.)
- Volkswirtschaftslehre, Ökonometrie und Finanzen (sonstige)
- Medizin (insg.)
- Health policy
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: European Journal of Health Economics, Jahrgang 10, Nr. SUPPL. 1, 01.2010, S. S21-S26.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Cancer management and reimbursement aspects in Germany
T2 - an overview demonstrated by the case of colorectal cancer
AU - Von Der Schulenburg, J. Matthias
AU - Prenzler, Anne
AU - Schurer, Willemien
PY - 2010/1
Y1 - 2010/1
N2 - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
AB - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
KW - Cancer management
KW - Colorectal cancer
KW - CRC
KW - Germany
KW - Health policy
UR - http://www.scopus.com/inward/record.url?scp=76649126203&partnerID=8YFLogxK
U2 - 10.1007/s10198-009-0194-x
DO - 10.1007/s10198-009-0194-x
M3 - Article
AN - SCOPUS:76649126203
VL - 10
SP - S21-S26
JO - European Journal of Health Economics
JF - European Journal of Health Economics
SN - 1618-7598
IS - SUPPL. 1
ER -